Why the study?
Does cardiac rehabilitation participation reduce all-cause mortality in patients with cardiovascular disease?
Does cardiac rehabilitation participation reduce all-cause mortality in patients with cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Cardiac rehabilitation participation is associated with a significant reduction in all-cause mortality among patients with cardiovascular disease, supporting its wider prescription in secondary prevention.
In this cohort study, CR participation was associated with a 32% risk reduction in all-cause mortality, and this benefit was independent of sex, age, socioeconomic status, and comorbidity. These findings reinforce the importance of CR participation in secondary prevention and highlight the possibility that CR should be prescribed more widely to vulnerable patients with CVD, such as older adults with chronic diseases or multimorbidity.
No takes yet. Share an insight, caveat, or question.
Eijsvogels et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: